<DOC>
	<DOCNO>NCT00590187</DOCNO>
	<brief_summary>The main objective study learn sapacitabine treatment likely keep cancer check least one year AML patient least 70 year age old MDS patient least 60 year age .</brief_summary>
	<brief_title>Efficacy Study Oral Sapacitabine Treat Acute Myeloid Leukemia Elderly Patients</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>A histologically pathologically confirm diagnosis AML base WHO classification previously untreated systemic therapy first relapse achieve complete remission initial induction , consolidation and/or maintenance therapy MDS IPSS score intermediate 2 high risk risk previously treat hypomethylating agent Age 70 year old AML 60 year old MDS Eastern Cooperative Oncology Group ( ECOG ) performance status 02 Adequate renal function define serum creatinine equal less 1.5 x upper limit normal ( ULN ) Adequate liver function define total bilirubin direct bilirubin equal le 1.5 x ULN ; alanine aminotransferase ( ALT SGPT ) equal less 2.5 x ULN ( 5 x ULN tumor affect liver ) Life expectancy reasonably adequate evaluate treatment effect Patient must able swallow capsule Patients must least 2 week prior systemic therapy , radiation therapy , major surgery , investigational therapy , recover clinically significant toxicity prior treatment All men woman reproductive potential must agree practice effective contraception 4 week prior study entry , entire study period one month study unless documentation infertility exist Ability understand willingness sign inform consent form AML subtype acute promyelocytic leukemia Having receive one induction systemic therapy AML receive standard dose high dose araC contain regimen MDS Patients known central nervous system ( CNS ) involvement leukemia Uncontrolled intercurrent illness include , limited ongoing active infection , active cancer ( ) AML , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Patients receive intravenous antibiotic infection control may include study Known HIVpositive</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>